Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.88 EUR | +4.73% | +0.70% | -21.31% |
Sales 2024 * | 64.79M 69.51M | Sales 2025 * | 75.94M 81.48M | Capitalization | 60.08M 64.46M |
---|---|---|---|---|---|
Net income 2024 * | -5M -5.36M | Net income 2025 * | -2M -2.15M | EV / Sales 2024 * | 1.3 x |
Net Debt 2024 * | 24.4M 26.18M | Net Debt 2025 * | 22.75M 24.41M | EV / Sales 2025 * | 1.09 x |
P/E ratio 2024 * |
-16.5
x | P/E ratio 2025 * |
-20.2
x | Employees | 311 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.38% |
Latest transcript on BRAIN Biotech AG
1 day | +1.27% | ||
1 week | -3.17% | ||
Current month | -20.29% | ||
1 month | -25.27% | ||
3 months | -26.67% | ||
6 months | -29.31% | ||
Current year | -24.86% |
Managers | Title | Age | Since |
---|---|---|---|
Adriaan Moelker
CEO | Chief Executive Officer | 60 | 20-01-31 |
Director of Finance/CFO | 54 | 20-04-30 | |
Alexander Pelzer
CTO | Chief Tech/Sci/R&D Officer | 38 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Majerus
CHM | Chairman | 63 | 19-03-06 |
Stephen Catling
BRD | Director/Board Member | 59 | 20-10-13 |
Director/Board Member | 70 | 20-10-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2.88 | +4.73% | 1 078 |
24-04-25 | 2.75 | -1.43% | 1,774 |
24-04-24 | 2.79 | +0.36% | 21,628 |
24-04-23 | 2.78 | -1.07% | 14,114 |
24-04-22 | 2.81 | -1.75% | 14,482 |
Delayed Quote Xetra, April 25, 2024 at 11:36 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.86% | 64.36M | |
-28.65% | 213M | |
+30.98% | 69.69M |
- Stock Market
- Equities
- BNN Stock